LENSAR, Inc.
LNSR
$5.67
-$0.02-0.35%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/8/2026
-
MarketBeat
6/1/2026
-
Yahoo! Finance: News
6/1/2026
-
Nasdaq News: Markets
6/1/2026
-
Nasdaq News: Markets
6/1/2026
-
Fool.com Headlines
6/1/2026
-
Fool.com Headlines
5/9/2026
-
The Cerbat Gem
5/9/2026
-
MarketBeat
5/8/2026
-
MarketBeat
5/8/2026
-
Seeking Alpha - Healthcare
5/8/2026
-
SeekingAlpha
5/8/2026
-
Seeking Alpha - Healthcare
5/8/2026
-
Globe Newswire
4/30/2026
-
Globe Newswire
4/30/2026
-
MarketBeat
4/20/2026
-
Yahoo! Finance: News
4/20/2026
-
Insider Monkey
4/15/2026
-
MarketBeat
4/4/2026
-
Insider Monkey
4/2/2026
-
TipRanks Financial Blog
4/1/2026
-
MarketBeat
4/1/2026
-
TipRanks Financial Blog
3/31/2026
-
SeekingAlpha
3/31/2026
-
Seeking Alpha: Transcripts
3/31/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 8, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
888 536 7271
Address
2800 Discovery Drive
Orlando, FL 32826
Orlando, FL 32826
Country
Year Founded
Business Description
Sector
Industry
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or...
more